• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rapport Therapeutics, Inc. - Common Stock (NQ: RAPP )

24.62 +0.09 (+0.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 30,886
Open 25.61
Bid (Size) 20.40 (5)
Ask (Size) 39.47 (2)
Prev. Close 24.53
Today's Range 24.33 - 25.61
52wk Range 16.55 - 29.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
October 18, 2024
Via Benzinga
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences
September 05, 2024
From Rapport Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
+18.37%
+18.37%
1 Month
+34.24%
+34.24%
3 Month
+19.98%
+19.98%
6 Month
+18.37%
+18.37%
1 Year
+18.37%
+18.37%

More News

Read More
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
August 29, 2024
From Rapport Therapeutics, Inc.
Via GlobeNewswire
The 3 Best Healthcare Stocks to Buy in August 2024
August 12, 2024
Via InvestorPlace
RAPP Stock Earnings: Rapport Therapeutics Misses EPS for Q2 2024
August 10, 2024
Via InvestorPlace
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
August 08, 2024
From Rapport Therapeutics, Inc.
Via GlobeNewswire
3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns
August 06, 2024
Via InvestorPlace
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain
July 29, 2024
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
June 12, 2024
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Why Contango Ore Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 11, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap